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Abstract
Background: Dizziness and vertigo symptoms are commonly seen in emergency room (ER). However, these patients are
often discharged without a definite diagnosis. Conflicting data regarding the vascular event risk among the dizziness or
vertigo patients have been reported. This study aims to determine the risk of developing stroke or cardiovascular events in
ER patients discharged home with a diagnosis of dizziness or vertigo.
Methodology: A total of 25,757 subjects with at least one ER visit in 2004 were identified. Of those, 1,118 patients were
discharged home with a diagnosis of vertigo or dizziness. A Cox proportional hazard model was performed to compare the
three-year vascular event-free survival rates between the dizziness/vertigo patients and those without dizziness/vertigo
after adjusting for confounding and risk factors.
Results: We identified 52 (4.7%) vascular events in patients with dizziness/vertigo and 454 (1.8%) vascular events in patients
without dizziness/vertigo. ER patients discharged home with a diagnosis of vertigo or dizziness had 2-fold (95% confidence
interval [CI], 1.35–2.96; p,0.001) higher risk of stroke or cardiovascular events after adjusting for patient characteristics, co-
morbidities, urbanization level of residence, individual socio-economic status, and initially taking medications after the
onset of dizziness or vertigo during the first year.
Conclusions: ER patients discharged home with a diagnosis of dizziness or vertigo were at a increased risk of developing
subsequent vascular events than those without dizziness/vertigo after the onset of dizziness or vertigo. Further studies are
warranted for developing better diagnostic and follow-up strategies in increased risk patients.
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Introduction
Dizziness or vertigo is a common reason for visiting the
emergency room (ER), accounting for approximately 10% of total
ER visits in the Unites States and more than $1.6 billion in health
expenditures each year [1,2,3]. Although most patients with
vertigo or dizziness are discharged, a potentially serious underlying
disease, such as cerebrovascular events or myocardial infarction,
may be overlooked [4,5,6].
Findings on the risk of stroke associated with vertigo or dizziness
have not been consistent. A follow-up study of 121 patients found
that up to 5% of them had major morbidity such as stroke within
six months [7]. Kim et al. [8] reported that only 0.93% of ER
patients discharged home with a diagnosis of vertigo or dizziness
experienced a major vascular event during a follow-up of 180
days. In a population-based study, Kerber et al. [9] also reported a
low proportion of cerebrovascular events in patients presenting
with dizziness, vertigo or imbalance. However, several case reports
and a study by Chase et al. suggested that stroke or vascular events
are likely to happen among the vertigo or dizziness patients
[5,10,11,12].
The purpose of this study is to examine the incidence of vascular
events in such patients identified through the National Health
Insurance Research Database (NHIRD) in Taiwan. This allows
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35923for a comparison of the risk of vascular events between in ER
patients discharged home with a diagnosis of dizziness or vertigo
and those without [13].
Materials and Methods
Ethics statement
This study was initiated after approval by the Institutional
Review Board of Buddhist Dalin Tzu Chi General Hospital,
Taiwan. Since all identifying personal information was stripped
from the secondary files before analysis, the review board waived
the requirement for written informed consent from the patients
involved.
Database
The National Health Insurance program, which provides
compulsory universal health insurance, was implemented in
Taiwan in 1995. It enrolls up to 99% of the Taiwanese population
and contracts with 97% of all medical providers [14]. The
database contains comprehensive information on insured subjects,
including dates of clinical visits, diagnostic codes, details of
prescriptions and expenditure amounts. This study used the
Longitudinal Health Insurance Dataset for 2004–2006 released by
the Taiwan Nation Health Research Institute. The patients
studied did not differ statistically significantly from the larger
cohort in age, gender or health care costs, as reported by the
Taiwan National Health Research Institute (http://w3.nhri.org.
tw/nhird//date_cohort.htm) [15,16].
Study Population
We identified patients older than 18 years who visited the ER in
2004. We excluded those with any type of stroke (International
Classification of Diseases, 9th revision - Clinical Modification
[ICD-9-CM] codes 430–438), acute myocardial infarction (ICD-9-
CM 410), unstable angina (ICD-9-CM 411) or ventricular
arrhythmia (ICD-9-CM 427.1, 427.4, 427.5 or 427.69) diagnosed
before or during the index ER visit. After exclusion, we identified
1118 ER patients discharged home with a diagnosis of dizziness or
vertigo (ICD-9-CM 780.4 and 386.0–386.9) and 24639 ER
patients without a dizziness or vertigo diagnosis. Each patient
was tracked for three years from his or her first discharge in 2004
to identify outcomes including hemorrhagic or ischemic stroke
diagnosis codes (ICD-9-CM 430, 431, 433.61, 434.61, or 436.6),
acute myocardial infarction (ICD-9-CM 410), unstable angina
(ICD-9-CM 411) or ventricular arrhythmia (ICD-9-CM 427.1,
427.4, 427.5 or 427.69). To maximize case ascertainment, only
patients hospitalized for the above vascular events were included.
These patients were then linked to the administrative data for the
period 2004–2006 to calculate cardiovascular or cerebrovascular
disease-free survival time, with cases censored for patients who
drew back guarantees from the National Health Insurance
Program or were still robust without defined events at end of
follow-up (Figure 1).
Medications which could result in dizziness or vertigo before ER
visit were included for analysis. Medications consisted of
anticonvulsants (i.e., phenytoin or carbamazepine), antihyperten-
sives and drugs with hypotension as side effects (i.e., propranolol,
terazosin, doxazosin, prazosin, atenolol, furosemide, nifedipine,
verapamil, diltiazem, isosorbide dinitrate, lisinopril, amitriptyline,
chlorpromazine, or procholorperazine), and psychotropic agents
(i.e. , zolpidem, diazepam, alprazolam, or haloperidol).
The insurance enrollee category was used as a proxy measure of
socio-economic status (SES). SES is an important prognostic factor
for stroke and/or myocardial infarction [17,18]. The patients were
classified into two sub-groups: high individual SES (civil servants,
regular or full-time paid personnel with a government affiliation,
employees of privately owned institutions), and low individual SES
(self-employed individuals, members of the farmers or fishermen’s
association, other employees, veterans, substitute service draftees,
and members of low-income families) [19].
Urbanization level of residence is also associated with vascular
events and were therefore included in our analysis [20,21]. We
recorded the level of urbanization as urban, and sub-urban
(urbanization level 1–3), or rural (urbanization level 4–7).
Statistical analysis
The SAS statistical package, version 9.2 (SAS Institute, Inc.,
Cary, NC), and SPSS version 15 (SPSS Inc., Chicago, IL) were
used for data analysis. Pearson’s chi-square test was used for
categorical variables, demographic characteristics (age group and
gender), comorbidities (hypertension, diabetes, coronary artery
disease, hyperlipidemia and atrial fibrillation) and initially taking
medications that may cause dizziness in ER patients with
dizziness/vertigo and those without.
The 3-year vascular event-free survival rate was estimated using
the Kaplan-Meier method. The cumulative risk of stroke or
cardiovascular event was estimated as a function of time from
initial treatment. Cox proportional hazard regression model with
time-dependent covariate was used to calculate the risk of stroke or
cardiovascular event for ER patients with dizziness or vertigo
versus those without, after adjustments for age, gender, hyperten-
sion, diabetes, coronary heart disease, hyperlipidemia, atrial
fibrillation, urbanization of residence, socioeconomic status, and
initially taking medications. To find useful predictors, we
constructed univariate and multivariable Cox models to explore
the effect of age, gender, comorbidities, urbanization of residence,
socioeconomic status and initially taking medications on the risk of
vascular outcomes for patients with dizziness or vertigo. A p,0.05
was considered statistically significant in the regression models.
Figure 1. Flow diagram of the population-based study.
doi:10.1371/journal.pone.0035923.g001
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between dizziness/vertigo and vascular events, determining the
risk of developing stroke or cardiovascular events in ER patients
discharged home with a diagnosis of headache (ICD-9-CM 780.4)
was further conducted. This dataset were selected from the
Longitudinal Health Insurance Dataset for the period 2004–2006
as previously described. The outcomes measures were similar to
those which was applied in dizziness and vertigo patients. Patients
with any type of vascular events diagnosed before or during the
index ER visit and those with specific diagnosis were excluded.
23165 patients (417 patients with headache and 22748 patients
without a diagnosis of headache) who had visited ER and further
discharged smoothly in 2004 were included. These patients were
tracked for three years and further lined to the administrative data
for the period 2004–2006 to estimate vascular event-free survival,
with cases censored for patients who drew back guarantees from
the National Health Insurance Program or were still robust
without defined events at end of follow-up.
Table 1. Baseline characteristics of the study population.
Variables
Entire population
(n=25757) n(%)
Dizziness or vertigo
patients (n=1118) n(%)
Patients without dizziness or
vertigo (n=24639) n(%) p value
Gender ,0.001
Male 12451 (48.3) 395 (35.3) 12056 (48.9)
Female 13306 (51.7) 723 (64.7) 12583 (51.1)
Age group ,0.001
18–44 14279 (55.4) 373 (33.4) 13906 (56.4)
45–54 4158 (16.1) 216 (19.3) 3942 (16.0)
55–64 2632 (10.2) 171 (15.3) 2461 (10.0)
65–74 2465 (9.6) 194 (17.4) 2271 (9.2)
§75 2223 (8.6) 164 (14.7) 2059 (8.4)
Hypertension ,0.001
Yes 832 (3.2) 96 (8.6) 736 (3.0)
No 24925 (96.8) 1022 (91.4) 23903 (97.0)
Diabetes ,0.001
Yes 612 (2.4) 50 (4.5) 562 (2.3)
No 25145 (97.6) 1068 (95.5) 24077 (97.7)
Coronary heart disease 0.135
Yes 474 (1.8) 14 (1.3) 460 (1.9)
No 25283 (98.2) 1104 (98.7) 24179 (98.1)
Hyperlipidemia 0.450
Yes 18 (0.1) 0 (0.0) 18 (0.1)
No 25739 (99.9) 1118 (100.0) 24621 (99.9)
Atrial fibrillation 0.655
Yes 28 (0.1) 1 (0.1) 27 (0.1)
No 25729 (99.9) 1117 (99.9) 24612 (99.9)
Urbanization 0.063
Urban and suburban 20204 (78.4) 852 (76.2) 19352 (78.5)
Rural 5553 (21.6) 266 (23.8) 5287 (21.5)
Individual socioeconomic status ,0.001
High 12609 (49.0) 463 (41.4) 12146 (49.3)
Low 13148 (51.0) 655 (58.6) 12493 (50.7)
Anticonvulsants 0.001
Yes 350 (1.4) 31 (2.8) 319 (1.3)
No 25407 (98.6) 1087 (97.2) 24320 (98.7)
Antihypertensives ,0.001
Yes 4249 (16.5) 345 (30.9) 3904 (15.8)
No 21508 (83.5) 773 (69.1) 20735 (84.2)
Psychotropic agents ,0.001
Yes 3341 (13.0) 281 (25.1) 3060 (12.4)
No 22416 (87.0) 837 (74.9) 21579 (87.6)
doi:10.1371/journal.pone.0035923.t001
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The distribution of demographic characteristics, selected
morbidities and initially taking medications for the two cohorts
is shown in Table 1. Dizziness/vertigo patients were significantly
older and more likely to be female. They were also more likely to
have hypertension, and diabetes, had lower socioeconomic status,
and took anticonvulsants, antihypertensives and psychotropic
agents than those without dizziness/vertigo.
At the end of follow-up, 506 patients had vascular events, 52
(4.7%) in the patients with dizziness or vertigo and 454(1.8%) in
those without. The six-month cumulative risk of vascular event,
stroke, or cardiovascular events was 1.3% (95% Confidence
interval [CI], 0.7–1.9), 1% (95% CI, 0.4–1.6), and 0.4% (95% CI,
0–0.8), respectively for the patients with dizziness or vertigo. In
patients with dizziness or vertigo, the cumulative risk of vascular
event, stroke, or cardiovascular events was 5.1% (95% CI, 3.7–
6.5), 3.3% (95% CI, 2.0–4.5), and 2.0% (95% CI, 1.0–3.0),
respectively at the end of follow-up (Table 2). Patients with
dizziness or vertigo had an increased risk of vascular events
(Figure 2). Table 3 shows in model with time interactions, the
estimated of hazard ratios of dizziness/vertigo (HR=0.65, 95%
CI, 050–0.84; p=0.001) were less than 1, which implied that the
effects of dizziness/vertigo and comorbidities are much stronger at
the beginning of the follow-up period and weaker after long-term
follow-up. We further separated the follow-up time during the first
year and during the 2
nd and 3
rd year. In Table 4, we see that the
effect of dizziness or vertigo are much stronger for vascular events
in the first year (HR=2, 95% CI, 1.35–2.96). Among the ER
patients with dizziness or vertigo discharged home, predictors of
vascular events were analyzed using Cox regression model. In
univariate analysis, age, diabetes, coronary artery disease, male
gender, residence in rural area and initially taking antihypertensive
drugs were associated with increased risk for vascular events.
Increased age (HR=1.06; 95% CI, 104–1.08), and coronary
artery disease (HR=5, 95% CI, 1.82–16) remained independent
risk factors for vascular events in the multivariable model (Table 5).
We further identify 417 ER patients discharged home with a
diagnosis of headache and determine the risk of developing
vascular events. They were more likely to be older, to be female,
and had hypertension (Table 6). There was no statistically
difference in risk of vascular events between patients with
headache and patients without headache (Table 7).
Discussion
Our data showed that ER patients discharged home with a
diagnosis of dizziness or vertigo incurred a two-fold higher risk for
subsequent vascular events after adjusting for patient character-
istics, comorbidities, and other confounding factors during the first
year. Further studies are warranted for developing diagnostic and
follow-up strategies.
The strengths of our study are its being a large population-based
study (n=25,757), nearly complete follow-up of any hospitaliza-
tion for vascular events among the whole study population (99%)
and routine monitoring of accuracy of diagnosis by the National
Health Insurance Bureau of Taiwan. We see the association
between ER visit for headache and vascular outcomes in order to
test the specific association of dizziness/vertigo and vascular
events. There was no statistically association between headache
Figure2.Cumulative risk ofvascularevents fortheER dizziness/
vertigo patients and patients without dizziness/vertigo.
doi:10.1371/journal.pone.0035923.g002
Vascular Events Risk in ER Dizziness Patients
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35923and vascular events. The specific association of dizziness/vertigo
and vascular events appeared to be specific to dizziness/vertigo
but not headache. One previous study showed 180-day cumulative
incidence of vascular event, cerebrovascular event, or cardiovas-
cular event was 0.93%, 0.63%, and 0.32%, respectively and
revealed that most of the vascular events developed within the first
month [8]. Our series revealed the six-month cumulative risk of
vascular event, stroke, or cardiovascular events was 1.3%, 1%, and
0.4%, respectively. The risk for vascular events remained
significantly higher during the first year follow-up and became
insignificant between second and third years. In another follow-up
study, up to 5% of major vascular events developed within six
months. However, up to 18% loss to follow-up may prevent us to
interpret these results correctly [7]. Our results suggest that ER
patients discharged home with a diagnosis of dizziness or vertigo
have a higher risk for stroke, cardiovascular events and all vascular
events, compared to those without dizziness/vertigo after adjusting
patient characteristics, co-morbidities, and other confounding
factors.
Our finding of up to 4.7% of vascular events among patients
with dizziness/vertigo over 3-year follow-up may justify utilizing
more intensive evaluation to identify and treat serious cases. We
found a similar pattern of cumulative risks for vascular events as
previously reported, with more early cerebrovascular events, but
not more early cardiovascular events [8]. Early vascular events
within several months after discharge from the ER may be
Table 2. Cumulative risk of vascular events in patients with dizziness/vertigo and those without.
Variables 6 months 1-year 2-year 3-year
Events (%) Risk (%) (95% CI) Events (%) Risk (%) (95% CI) Events (%) Risk (%) (95% CI) Events (%) Risk (%) (95% CI)
Stroke
Patient without
dizziness/vertigo
81 (0.3) 0.3 (0.3–0.3) 131 (0.5) 0.5 (0.5–0.5) 236 (1.0) 1.0 (0.8–1.2) 290 1.2) 1.4 (1.2–1.6)
Dizziness/vertigo
patients
11(1.0) 1.0 (0.4–1.6) 20(1.8) 1.8 (1–2.6) 29 (2.6) 2.7 (1.7–3.7) 34 (3.0) 3.3 (2.0–4.5))
Cardiovascular events
Patient without
dizziness/vertigo
45 (0.2) 0.2 (0.2–0.2) 82 (0.3) 0.3 (0.3–0.3) 131 (0.5) 0.6 (0.6–0.6) 170 (0.7) 0.8 (0.6–1.0)
Dizziness/vertigo
patients
4 (0.4) 0.4 (0–0.8) 10 (0.9) 0.9 (0.3–1.5) 19 (1.7) 1.8 (1.0–2.6) 20 (1.8) 2.0 (1.0–3.0)
All vascular events
Patient without
dizziness/vertigo
126 (0.5) 0.5 (0.5–0.5) 211 (0.9) 0.9 (0.7–1.1) 363 (1.5) 1.5 (1.3–1.7) 454 (1.8) 2.2 (2.0–2.4)
Dizziness/vertigo
patients
15 (1.3) 1.3 (0.7–1.9) 29 (2.6) 2.6 (1.6–3.6) 46 (4.1) 4.2 (3.0–5.4) 52 (4.7) 5.1 (3.7–6.5)
doi:10.1371/journal.pone.0035923.t002
Table 3. Hazard ratios of all vascular events among 25,757 patients.
Variables Model without time interactions Model with time interactions
Hazard ratio 95% CI p value Hazard ratio 95% CI p value
Dizziness/Vertigo 1.62 1.21–2.17 0.001 4.60 2.40–8.33 ,0.001
Age, per year 1.07 1.06–1.07 ,0.001 1.31 1.29–1.33 ,0.001
Hypertension 1.34 1.01–1.81 0.040 1.66 1.24–2.23 0.001
Diabetes 1.41 1.01–1.97 0.041 2.02 1.44–2.82 ,0.001
Coronary heart disease 1.89 1.37–2.62 ,0.001 2.33 1.66–3.26 ,0.001
Atrial fibrillation 3.13 1.17–8.38 0.023 1.62 0.51–5.20 0.416
Male gender 1.27 1.07–1.52 0.008 1.11 0.92–1.33 0.284
Residence in rural area 1.18 0.98–1.44 0.089 1.07 0.88–1.32 0.492
Low individual SES 1.07 0.87–1.31 0.515 1.56 1.25–1.95 ,0.001
Anticonvulsants 1.56 0.98–2.49 0.059 1.75 1.10–2.79 0.019
Antihypertensive drug 1.47 1.22–1.78 ,0.001 1.44 1.17–1.76 ,0.001
Psychotrophic drug 1.06 0.85–1.32 0.611 1.07 0.85–1.33 0.582
Dizziness/Vertigo 6log(time) - - - 0.65 0.50–0.84 0.001
Age 6log(time) - - - 0.93 0.92–0.93 ,0.001
Abbreviation: 95% CI, 95% confidence interval.
doi:10.1371/journal.pone.0035923.t003
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patients without dizziness/vertigo stratified by time; 240 vascular events in the first year of follow-up and 266 vascular events
between 2
nd and 3
rd years.
Variables Events in the 1
st year Events between 2
nd and 3
rd years
No. of events Hazard ratio* 95% CI p value No. of events Hazard ratio* 95% CI p value
Stroke
Patient without dizziness/
vertigo
131 1.00 – – 157 1.00 - -
Dizziness/vertigo patients 20 2.07 1.29–3.34 0.003 13 1.08 0.61–1.92 0.781
Cardiovascular events
Patient without dizziness/
vertigo
82 1.00 - - 87 1.00 - -
Dizziness/vertigo patients 10 1.94 1–3.76 0.051 10 1.72 0.89–3.34 0.107
All vascular events
Patient without dizziness/
vertigo
211 1.00 - - 243 1.00 - -
Dizziness/vertigo patients 29 2.00 1.35–2.96 0.001 23 1.31 0.85–2.02 0.216
Abbreviation: 95% CI, 95% confidence interval.
*Adjusted for age, gender, hypertension, diabetes, coronary heart disease, hyperlipidemia, atrial fibrillation, urbanization of residence, individual socioeconomic status
and medication.
doi:10.1371/journal.pone.0035923.t004
Table 5. Predictors of vascular events among ER patients discharged home with diagnosis of dizziness or vertigo (n=1118).
Variable Hazard ratio (95% CI)
All vascular events Stroke Cardiovascular events
Univariate model*
Age, per year 1.07 (1.04–1.09) 1.07 (1.04–1.10) 1.06 (1.03–1.10)
Male gender 1.87 (1.08–3.23) 2.10 (1.04–4.12) 1.85 (0.77–4.45)
Hypertension 1.71 (0.77–3.80) 2.37 (0.98–5.71) 0.56 (0.08–4.20)
Diabetes 1.83 (0.66–5.07) 2.91 (1.02–8.25) 1.13 (0.15–8.47)
Coronary heart disease 7.61 (2.74–21) 5.18 (1.24–22) 9.34 (2.17–41)
Residence in rural area 2.02 (1.16–3.54) 1.76 (0.87–3.55) 2.62 (1.09–6.33)
Low individual SES 1.43 (0.80–2.54) 1.67 (0.80–3.48) 1.28 (0.51–3.20)
Anticonvulsants 2.25 (0.70–7.22) 2.29 (0.55–9.57) 1.90 (0.26–14)
Antihypertensive drug 2.35 (1.36–4.05) 1.43 (0.72–2.86) 4.34 (1.73–11)
Psychotrophic drug 1.64 (0.93–2.91) 0.94 (0.42–2.07) 3.83 (1.59–9.25)
Multivariable regression model*
Age, per year 1.06 (1.04–1.08) 1.07 (1.04–1.10) 1.06 (1.03–1.10)
Male gender 1.95 (0.79–4.81) 1.58 (0.79–3.17) 1.95 (0.79–4.81)
Hypertension 0.87 (0.38–2.02) 1.33 (0.53–3.31) 0.35 (0.03–2.02)
Diabetes 1.78 (0.42–3.30) 1.78 (0.62–5.11) 0.79 (0.10–6.08)
Coronary heart disease 5.31 (1.82–16) 3.60 (0.80–36) 7.50 (1.63–34)
Residence in rural area 1.79 (0.98–3.28) 1.40 (0.65–3.03) 2.4 1(0.94–6.17)
Low individual SES 0.68 (0.36–1.27) 0.85 (0.39–1.89) 0.53 (0.19–1.47)
Anticonvulsants 2.05 (0.59–7.14) 2.04 (0.45–9.22) 2.45 (0.29–21)
Antihypertensive drug 1.52 (0.86–2.69) 0.99 (0.48–2.04) 2.29 (0.88–6.01)
Psychotrophic drug 1.38 (0.76–2.51) 0.81 (0.36–1.85) 3.3 (1.29–8.28)
Abbreviation: 95% CI, 95% confidence interval.
*History of hyperlipidemia and atrial fibrillation were not included in the regression model due to lack of data association between vascular outcomes and these two co-
morbidities in dizziness/vertigo patients.
doi:10.1371/journal.pone.0035923.t005
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flattening in the curve may reflect the background rate of
cardiovascular risk [8]. Dizziness is a vague term which may refer
to vertigo, near-fainting, psychological problems, ocular-vestibular
disease or disequilibrium [22]. One previous study found that most
dizziness in ER patients was attributable to medical causes [23].
When considered in aggregate, general medical diagnoses were
more common than otovestibular ones, and nearly half of the
medical disorders diagnosed were cardiovascular. This observation
indicates that patients with dizziness or vertigo may have
underlying cardiovascular disease. On the other hand, dizziness
or isolated vertigo which results from transient ischemia to the
vestibular labyrinthine is a common symptom in nonfocal
transient neurological attacks. Our results are in agreement with
those of Bos et al. and may be partially explained by their
observations [4]. They challenge the strong but unfounded
conviction that nonfocal transient neurological attacks are
harmless and first reported their association with increased risk
for dementia (HR, 1.59; 95% CI, 1.11–2.26) and stroke (HR, 1.56;
95% CI, 1.08–2.28). Similarly, in our series, ER patients
discharged home with a diagnosis of dizziness or vertigo also
had increased risk for vascular events (HR, 2; 95% CI, 1.35–2.96)
during the first year follow-up.
Widespread uncertainty involved in decision related to
dizziness/vertigo presentations still exists in the ER even after
lengthy evaluations and extensive use of diagnostic tests, including
neuroimaging [23]. We found that increasing age and coronary
artery disease were independent risk factors for stroke and all
vascular events among ER patients discharged with a diagnosis of
dizziness or vertigo. For these increased risk patients, emergency
neurological/cardiac consultation or referral to out-patient clinics
might be considered because of the possibility of misdiagnosis of
dangerous disorders in the ER. Furthermore, increased risk
patients need to be educated to identify the warning signs of stroke,
transient ischemic attack and myocardial ischemia. Given that
older people are most vulnerable to vascular events, it is
particularly important to maximize the potential for early
recognition and early medical intervention in this group [24,25].
Table 6. Baseline characteristics of ER patients with headache and patients without headache.
Variables
Entire population
(n=23165) n(%)
Headache patients
(n=417) n(%)
Patients without
headache (n=22748) n(%) p value
Gender ,0.001
Male 11108(48) 132(31.7) 10976(48.3)
Female 12057(52) 285(68.3) 11722(51.7)
Age group ,0.001
,45 12721(54.9) 274(65.9) 12447(54.7)
45–54 3758(16.2) 65(15.6) 3693(16.2)
55–64 2408(10.4) 45(10.8) 2363(10.4)
65–74 2264(9.8) 19(4.6) 2245(9.9)
§75 2014(8.7) 14(3.4) 2000(8.8)
Hypertension ,0.001
Yes 797(3.4) 32(4) 765(3.4)
No 22368(96.6) 385(96) 21983(96.6)
Diabetes 0.057
Yes 547(2.4) 4(1) 543(2.4)
No 22618(97.6) 413(99) 22205(97.6)
Coronary heart disease 0.009
Yes 465(2) 1(0.2) 464(2)
No 22700(98) 416(99.8) 22284(98)
Hyperlipidemia 0.761
Yes 15(0.1) 0(0) 15(0.1)
No 23150(99.9) 417(100) 22733(99.9)
Atrial fibrillation 0.601
Yes 28(0.1) 0(0) 28(0.1)
No 23137(99.9) 417(100) 22720(99.9)
Urbanization 0.298
Urban and suburban 18201(78.6) 319(76.5) 17882(78.6)
Rural 4964(21.4) 98(23.5) 4866(21.4)
Individual socioeconomic
status
0.583
High 11252(48.6) 197(47.2) 11055(48.6)
Low 11913(51.4) 220(52.8) 11693(51.4)
doi:10.1371/journal.pone.0035923.t006
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vertigo, patients need watchful attention to prevent vascular events
for several years. Although the incidence is relatively low,
cardiovascular and cerebrovascular events remain the main causes
of death and adult disability worldwide. If misdiagnosed, some of
these patients can have poor outcomes. Widely used diagnostic
strategies with categories such as vertigo, lightheadedness, and
disequilibrium are difficult to apply in the ER setting for acute
decision making [23]. Given this diagnostic uncertainty, identifi-
cation of increased risk patients is important. No guidelines
currently exist for the primary prevention of stroke or cardiovas-
cular events in increased risk vertigo or dizziness patients, and
studies evaluating the role of antiplatelet agents for such patients
are warranted.
This study has several limitations. First, the diagnosis of
dizziness or vertigo, stroke, myocardial infarction, ventricular
arrhythmia and any other co-morbid conditions are completely
dependent on ICD-9-CM codes. Due to using deidentified
administrative data, a direct validation of accuracy of diagnosis
and outcomes were not possible with chart review. Nonetheless,
the National Health Insurance Bureau of Taiwan randomly
reviews the charts and interviews patients to verify the accuracy of
diagnosis. Hospitals with outlier chargers or practice may undergo
an audit, with subsequent heavy penalties for malpractice or
discrepancies. We used previously validated algorithms with high
accuracy to identify outcomes from discharge diagnosis codes. The
accuracy of the National Health Insurance Research Database in
recording ischemic stroke diagnoses is as high as 95% [26].
Second, detailed information on myocardial infarction, unstable
angina, ventricular arrhythmia, or strokes cannot be exactly
extracted from ICD-9-CM codes, which prevents further sub-
group analysis. Further studies linking administrative data and
primary hospitalization information are warranted. Third, for the
analysis of the initially taking medications that may cause dizziness
or vertigo, binary event of ‘‘yes’’ versus ‘‘no’’ was recorded. The
length of time and dosage which patients were on these
medications were not clearly defined. More detailed research for
analyzing the impact of these medications is necessary in the
future. Fourth, only dizziness or vertigo patients who were
considered safe enough to be discharged home were included in
our series. Our results were unable to be generalized to patients
with dizziness/vertigo and specific diagnosis or those who were
further admitted to ward later.
In summary, this study reveals that ER patients with dizziness
or vertigo have a increased risk of subsequent vascular events and
that their likelihood of developing stroke or cardiovascular events
during the first year is 2 times higher than that of those without
dizziness or vertigo. Although the incidence is relatively low
(95.3% of patients remain event-free at 3 years), efforts to prevent
vascular events after the onset of dizziness or vertigo is worthy of
further study.
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